Technical Analysis for SERA - Sera Prognostics, Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 8.26 | -1.43% | -0.12 |
SERA closed down 1.43 percent on Friday, May 17, 2024, on 77 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -1.43% | |
| Oversold Stochastic | Weakness | -1.43% | |
| Lower Bollinger Band Walk | Weakness | -2.02% | |
| Wide Bands | Range Expansion | -2.02% | |
| Lower Bollinger Band Touch | Weakness | -2.02% |
| Alert | Time |
|---|---|
| Possible NR7 | 1 day ago |
| Possible Inside Day | 1 day ago |
| Down 2 % | 1 day ago |
| Down 1% | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Fertility Obstetrics Childbirth Women's Health Human Pregnancy Midwifery Pregnancy Preterm Birth
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Fertility Obstetrics Childbirth Women's Health Human Pregnancy Midwifery Pregnancy Preterm Birth
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.355 |
| 52 Week Low | 1.52 |
| Average Volume | 183,211 |
| 200-Day Moving Average | 5.45 |
| 50-Day Moving Average | 9.62 |
| 20-Day Moving Average | 9.79 |
| 10-Day Moving Average | 9.03 |
| Average True Range | 0.72 |
| RSI (14) | 36.71 |
| ADX | 25.84 |
| +DI | 16.40 |
| -DI | 25.14 |
| Chandelier Exit (Long, 3 ATRs) | 10.20 |
| Chandelier Exit (Short, 3 ATRs) | 10.26 |
| Upper Bollinger Bands | 11.71 |
| Lower Bollinger Band | 7.88 |
| Percent B (%b) | 0.1 |
| BandWidth | 39.15 |
| MACD Line | -0.37 |
| MACD Signal Line | -0.11 |
| MACD Histogram | -0.2561 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.74 | ||||
| Resistance 3 (R3) | 8.75 | 8.60 | 8.66 | ||
| Resistance 2 (R2) | 8.60 | 8.48 | 8.60 | 8.63 | |
| Resistance 1 (R1) | 8.43 | 8.40 | 8.36 | 8.42 | 8.61 |
| Pivot Point | 8.28 | 8.28 | 8.24 | 8.28 | 8.28 |
| Support 1 (S1) | 8.11 | 8.16 | 8.04 | 8.10 | 7.91 |
| Support 2 (S2) | 7.96 | 8.08 | 7.96 | 7.89 | |
| Support 3 (S3) | 7.79 | 7.96 | 7.86 | ||
| Support 4 (S4) | 7.78 |
